FDA Accepts Roche's sBLA for Lupus Nephritis Treatment | Contract Pharma

Retrieved on: 2025-03-05 15:44:12

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts Roche's sBLA for Lupus Nephritis Treatment | Contract Pharma. View article details on hiswai:

Excerpt

Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for ...

Article found on: www.contractpharma.com